Immix Biopharma Announces NXC-201 Clinical Data Abstract Accepted For Oral Presentation At 27th Annual Meeting Of ASGCT
- Updated clinical data for next-generation CAR-T NXC-201 in relapsed/refractory AL amyloidosis will be presented in Baltimore May 7-11, 2024